focus -WSS

focus

author：Wikipedia 2025-10-01 12:55:01 - browse：28289

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Device maker Teleflex to acquire urology company for $600M

WSS

New Alzheimer's drugs heat up race for early detection blood tests

Grail faces three suits alleging harassment, retaliation

Woman gored by Bison at Yellowstone

Mike Pence clashes with Tucker Carlson in Iowa

In the gardens at Boston Children's Hospital, families find sanctuary

Everything to know for the next Powerball drawing as jackpot hits $1 billion

focus

focus

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Psychedelics group wrestles with new pharma identity

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Trump demands the U.S. pay no more for drugs than other countries … again

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

What does generative AI mean for health care? We asked experts

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Trump demands the U.S. pay no more for drugs than other countries … again

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

hotspot

Why police arrested suspected Gilgo Beach killer away from his house

Device maker Teleflex to acquire urology company for $600M

Why patients can’t get everything they want on drug pricing

The haunting brain science of long Covid

Dems pitch expanding Medicare power to negotiate drug prices

What causes rare myocarditis in young men after Covid vaccines?

focus

explore

focus

hotspot